Howard Hughes Medical Institute’s McKesson MCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-27
Closed -$22.1K 310
2025
Q4
$22.1K Hold
27
0.01% 104
2025
Q3
$20.9K Hold
27
0.01% 107
2025
Q2
$19.8K Buy
+27
New +$19.1K 0.01% 111
2016
Q2
Sell
-3,841
Closed -$604K 175
2016
Q1
$604K Buy
3,841
+854
+29% +$138K 0.13% 76
2015
Q4
$589K Buy
2,987
+2,131
+249% +$402K 0.09% 90
2015
Q3
$158K Buy
+856
New +$181K 0.03% 126

Other funds holding MCK

Howard Hughes Medical Institute's MCK Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of McKesson (MCK) in Q1 2026, closing a stake of 27 shares — an estimated $22.1K sold.

Howard Hughes Medical Institute first reported a position in MCK in Q3 2015 and held it in 6 quarters. The position peaked at $604K in Q1 2016. 2,036 funds tracked by Wall St. Rank hold MCK as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining McKesson position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 27 McKesson shares in Q1 2026, an estimated $22.1K.
  • Howard Hughes Medical Institute first reported a position in McKesson in Q3 2015 and held it in 6 quarters.
  • Howard Hughes Medical Institute's McKesson position peaked at $604K in Q1 2016.
  • 2,036 funds tracked by Wall St. Rank held McKesson as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.